Summary
46 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- It cut its dividend by 67% last year.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.1 USD for 1 USD of yearly profit. Over the last five years it was 9.9 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.8% a year over 5 years. Over the last 3 years it grew by 12% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 54 USD
- Sales and administration 35 USD
- Taxes and other 2.1 USD
- Net profit 9.3 USD
Net profit, industry median (Banks - Regional) 21 USD
Out of every 100 USD of revenue, 9.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.12%
- Paid out of profit
- 2.3%
You receive $0.04 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 8
- Sell 0
Today's price within the analysts' price targets
The average target of $30.5 is 8.4% below today's price. 43% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.